Pro-Dex, Inc. (PDEX) Key Metrics

NASDAQ: PDEXValuation, returns, debt and efficiency ratios over 10 years.

PDEX valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$188.4M
Enterprise value
$241.6M
P/E (TTM)
14.1
10-yr median 13.8
Forward P/E
23.4
PEG ratio
—
Price / sales
2.4
10-yr median 1.8
Price / book
4.9
10-yr median 2.8
EV / EBITDA
11.9
10-yr median 10.0
Dividend yield
—
Beta
0.04

PDEX key metrics, FY2017–FY2026

Fiscal year ended June 30, 2026 · U.S. dollars

PDEX valuation Price multiples at each fiscal year-end price.

P/E ratio−13.0%
14.2
FY2026 · hover or tap a bar for each year
FY2017: 4.9 (−82.5%)FY2018: 17.8 (+261.3%)FY2019: 13.5 (−24.5%)FY2020: 11.9 (−11.6%)FY2021: 26.3 (+121.3%)FY2022: 13.1 (−50.1%)FY2023: 9.8 (−25.2%)FY2024: 33.0 (+235.8%)FY2025: 16.3 (−50.5%)FY2026: 14.2 (−13.0%)
FY2017FY2026
Price / sales+13.7%
2.5
FY2026 · hover or tap a bar for each year
FY2017: 1.1 (−0.7%)FY2018: 1.3 (+12.5%)FY2019: 2.1 (+59.7%)FY2020: 2.1 (+1.6%)FY2021: 2.9 (+37.2%)FY2022: 1.4 (−50.1%)FY2023: 1.5 (+5.6%)FY2024: 1.3 (−13.6%)FY2025: 2.2 (+69.1%)FY2026: 2.5 (+13.7%)
FY2017FY2026
Price / book+1.8%
4.1
FY2026 · hover or tap a bar for each year
FY2017: 1.8 (−30.0%)FY2018: 1.7 (−8.6%)FY2019: 3.3 (+96.2%)FY2020: 3.8 (+16.2%)FY2021: 4.7 (+24.1%)FY2022: 2.4 (−50.1%)FY2023: 2.2 (−6.8%)FY2024: 2.3 (+3.3%)FY2025: 4.0 (+76.2%)FY2026: 4.1 (+1.8%)
FY2017FY2026
EV / EBITDA+27.7%
14.1
FY2026 · hover or tap a bar for each year
FY2017: 6.0 (−49.5%)FY2018: 5.4 (−8.8%)FY2019: 9.2 (+69.4%)FY2020: 8.1 (−11.8%)FY2021: 19.6 (+141.0%)FY2022: 10.8 (−44.8%)FY2023: 7.4 (−31.4%)FY2024: 17.7 (+138.2%)FY2025: 11.1 (−37.4%)FY2026: 14.1 (+27.7%)
FY2017FY2026
Price / free cash flow
28.7
FY2026 · hover or tap a bar for each year
FY2017: 9.7 (−94.5%)FY2018: 13.4 (+38.4%)FY2019: 28.9 (+116.6%)FY2020: 13.6 (−52.9%)FY2023: 15.5FY2024: 13.4 (−13.1%)FY2026: 28.7
FY2017FY2026
Free cash flow yield+5.5 pts
3.5%
FY2026 · hover or tap a bar for each year
FY2017: 10.4% (+9.8 pts)FY2018: 7.5% (−2.9 pts)FY2019: 3.5% (−4.0 pts)FY2020: 7.3% (+3.9 pts)FY2021: −8.6% (−16.0 pts)FY2022: −4.2% (+4.4 pts)FY2023: 6.5% (+10.7 pts)FY2024: 7.4% (+1.0 pts)FY2025: −2.0% (−9.4 pts)FY2026: 3.5% (+5.5 pts)
FY2017FY2026

PDEX valuation history

Fiscal year-endToday10-year median

PDEX returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

PDEX debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

PDEX cash returned to shareholders

DividendsBuybacksFree cash flow

PDEX price vs earnings per share

Share price at year-endEPS (right axis)

PDEX key metrics

FY2017–FY2026
Pro-Dex, Inc. key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$194.2M$146.7M$70.1M$69.5M$60.0M$120.3M$72.7M$55.8M$28.9M$25.1M
Enterprise value$203.0M$156.1M$76.8M$80.2M$74.4M$134.7M$70.7M$50.0M$21.5M$20.3M
P/E ratio14.216.333.09.813.126.311.913.517.84.9
Price / sales2.52.21.31.51.42.92.12.11.31.1
Price / book4.14.02.32.22.44.73.83.31.71.8
Price / free cash flow28.7—13.415.5——13.628.913.49.7
Price / operating cash flow26.8—11.312.7——12.316.89.37.8
EV / sales2.62.31.41.71.83.22.01.81.00.9
EV / EBITDA14.111.117.77.410.819.68.19.25.46.0
EV / free cash flow30.0—14.717.9——13.325.910.07.8
Earnings yield7.0%6.1%3.0%10.2%7.6%3.8%8.4%7.4%5.6%20.3%
Free cash flow yield3.5%−2.0%7.4%6.5%−4.2%−8.6%7.3%3.5%7.5%10.4%
Dividend yield———0.1%—0.2%0.0%0.0%0.0%0.0%
Shareholder yield (dividends + buybacks)1.8%2.4%5.0%2.4%2.7%4.8%4.7%7.2%0.8%1.2%
Share price at fiscal year-end$58.55$43.64$19.64$19.10$15.95$30.56$17.82$12.98$6.65$6.15
Per share
Revenue per share$23.38$19.81$15.08$12.67$11.17$10.68$8.54$6.32$5.17$5.38
Earnings per share$4.12$2.67$0.60$1.95$1.21$1.16$1.50$0.97$0.37$1.25
Operating cash flow per share$2.18−$0.50$1.74$1.50−$0.23−$0.53$1.45$0.77$0.71$0.79
Free cash flow per share$2.04−$0.87$1.46$1.23−$0.67−$2.64$1.31$0.45$0.50$0.64
Cash per share$2.82$2.13$1.92$1.12$0.43$0.41$2.20$2.42$1.71$1.21
Book value per share$14.36$10.90$8.64$8.69$6.76$6.46$4.67$3.96$3.98$3.36
Tangible book value per share$12.19$10.89$8.63$8.66$6.73$6.43$4.63$3.93$3.86$3.26
Dividends per share———$0.02—$0.07$0.00$0.01$0.00$0.00
Capex per share$0.15$0.37$0.28$0.27$0.44$2.11$0.14$0.33$0.21$0.16
Debt per share$5.46$4.93$3.79$4.07$4.24$4.06$1.72$1.06$0.01$0.03
Shares outstanding3.3M3.4M3.6M3.6M3.8M3.9M4.1M4.3M4.3M4.1M
Change in shares outstanding−1.3%−5.9%−1.8%−3.4%−4.4%−3.5%−5.1%−1.1%+6.6%−2.3%
Returns & profitability
Return on equity (ROE)32.4%26.6%6.8%24.8%18.0%20.6%33.9%24.2%10.5%45.0%
Return on invested capital (ROIC)19.2%19.0%14.5%10.5%10.3%14.5%38.7%36.1%15.8%35.1%
Return on assets (ROA)20.1%15.8%4.1%14.0%9.3%11.4%21.6%18.3%8.9%37.0%
Return on tangible assets20.3%14.7%4.1%13.7%9.3%9.3%19.7%16.3%8.3%31.9%
Free cash flow margin8.7%−4.4%9.7%9.7%−6.0%−24.7%15.3%7.1%9.6%11.8%
Income quality (OCF / net income)0.53−0.192.910.77−0.19−0.450.960.801.910.64
Financial health
Total debt$18.1M$16.6M$13.5M$14.8M$16.0M$16.0M$7.0M$4.6M$41,000$119,000
Cash & short-term investments$9.3M$7.2M$6.8M$4.1M$1.6M$1.6M$9.0M$10.4M$7.4M$4.9M
Net debt$8.8M$9.4M$6.7M$10.7M$14.4M$14.4M−$2.0M−$5.8M−$7.4M−$4.8M
Debt / equity0.380.450.440.470.630.630.370.270.000.01
Debt / assets0.240.270.260.290.330.330.230.180.000.01
Net debt / EBITDA0.610.671.540.992.092.09−0.22−1.07−1.86−1.41
Current ratio4.103.232.843.202.742.744.345.106.404.62
Quick ratio2.451.711.661.531.631.632.763.644.673.42
Interest coverage16.012.912.910.811.014.629.922.7341.7227.8
Working capital$40.3M$32.7M$23.7M$21.3M$19.8M$19.8M$17.4M$17.5M$13.7M$9.3M
Invested capital$56.4M$46.0M$37.6M$42.3M$39.8M$39.8M$17.1M$11.2M$9.9M$8.9M
Tangible asset value$40.4M$36.6M$30.8M$31.5M$25.3M$25.3M$18.9M$16.9M$16.8M$13.3M
Net current asset value$26.4M$22.7M$15.0M$10.7M$7.5M$7.5M$10.6M$13.3M$13.6M$9.3M
Graham number$36.48$25.59$10.76$19.50$13.59$12.99$12.55$9.27$5.78$9.71
Graham net-net per share$2.74$2.03$0.92−$0.17−$1.11−$1.06$1.20$1.88$2.32$1.60
Capital allocation
Dividends paid———$89,000—$259,000$15,000$23,000$0$0
Share buybacks (net)$3.4M$3.5M$3.5M$1.5M$1.6M$5.5M$3.4M$4.0M$220,000$312,000
Dividend payout ratio———1.3%—5.7%0.2%0.6%0.0%0.0%
Dividends + buybacks / free cash flow50.4%—67.2%36.5%——63.8%207.8%10.2%12.0%
Capex / revenue0.6%1.9%1.8%2.1%4.0%19.8%1.6%5.1%4.2%2.9%
Capex / operating cash flow6.7%—15.9%17.8%——9.6%42.0%30.2%19.7%
Capex / depreciation0.351.010.851.142.3012.110.993.191.681.15
Stock-based compensation / revenue0.9%0.8%1.1%1.7%3.0%2.1%0.8%0.1%0.9%0.0%
R&D / revenue4.3%5.5%5.9%6.1%7.1%7.1%6.6%6.9%8.4%5.6%
SG&A / revenue10.3%7.8%7.8%9.1%11.9%11.9%10.8%10.7%11.8%14.2%
Efficiency
Days sales outstanding91.186.080.8100.3133.689.248.555.363.054.9
Days of inventory on hand149.8145.3146.0157.9160.1132.0121.8111.694.082.3
Days payables outstanding30.435.431.533.047.536.133.332.328.224.7
Cash conversion cycle (days)210.4195.9195.3225.3246.1185.1137.0134.5128.8112.5
Receivables turnover4.014.244.523.642.734.097.536.605.796.65
Payables turnover11.9910.3211.6011.077.6910.1010.9511.3012.9514.76
Inventory turnover2.442.512.502.312.282.763.003.273.884.43
Asset turnover1.141.171.030.910.861.051.231.201.241.60
Average receivables$19.3M$15.7M$11.9M$12.7M$15.4M$10.3M$4.6M$4.1M$3.9M$3.3M
Average payables$4.4M$4.6M$3.4M$3.0M$3.8M$2.9M$2.0M$1.5M$1.1M$1.0M
Average inventory$21.8M$18.7M$15.7M$14.4M$12.7M$10.5M$7.2M$5.3M$3.7M$3.3M
Intangibles / total assets9.7%0.0%0.1%0.2%0.2%0.2%0.5%0.5%2.5%2.6%

Computed from PDEX's annual financial statements (latest annual report filed September 3, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

PDEX valuation and financial ratios

At the end of fiscal 2026 (June 30, 2026), Pro-Dex traded at 14.2 times earnings, against a 10-year median of 13.8. Based on the latest twelve months, the trailing P/E is 14.1 and the forward P/E is 23.4. Pro-Dex earned a return on equity of 32.4% and a return on invested capital of 19.2% in fiscal 2026. It ended the year with $18.1 million of debt and $9.3 million in cash and short-term investments, net debt of $8.8 million. It returned $3.4 million to shareholders: $0 in dividends and $3.4 million in share buybacks, 50% of free cash flow. The share count fell 18.7% from 4.1M to 3.3M over 9 years.

See the PDEX income statement, the PDEX chart for price history, or the PDEX stock overview for the latest quote and news.

PDEX key metrics FAQ

What is Pro-Dex's P/E ratio?

Pro-Dex's trailing P/E ratio is 14.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 23.4. At the end of fiscal 2026 it was 14.2, compared with a 10-year median of 13.8.

What is Pro-Dex's EV/EBITDA?

Pro-Dex's enterprise value was 14.1 times EBITDA at the end of fiscal 2026 (enterprise value $203.0 million, EBITDA $14.4 million); the current EV/EBITDA is 11.9.

What is Pro-Dex's return on equity?

Pro-Dex's return on equity (ROE) was 32.4% in fiscal 2026: net income of $13.7 million on average shareholders' equity of $42.1 million.

What is Pro-Dex's ROIC?

Pro-Dex's return on invested capital was 19.2% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Pro-Dex have?

Pro-Dex had total debt of $18.1 million at the end of fiscal 2026, a debt-to-equity ratio of 0.38 and $8.8 million of net debt (0.61 times EBITDA).

Does Pro-Dex buy back its shares?

Yes. Pro-Dex spent $3.4 million on net share repurchases in fiscal 2026 Shares outstanding changed −1.3% over the year, to 3.3M..

What is Pro-Dex's free cash flow yield?

Pro-Dex generated $6.8 million of free cash flow in fiscal 2026, a free cash flow yield of 3.5% on its market value at year-end ($194.2 million).

What is Pro-Dex's current ratio?

Pro-Dex's current ratio was 4.10 at the end of fiscal 2026: current assets were 4.10 times current liabilities.

Medical Instruments & Supplies key metrics